Catalyst Event

Danaher Corp (DHR) · Other

From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)

4/13/2026, 12:00:00 AM

OtherSentiment: Positive

Beckman Coulter Diagnostics received CE Mark approval for its Access MeMed BV assay on 2026-04-13; positive impact estimated as it expands the product portfolio in Europe.

Korean Translation

2026년 4월 13일 자회사 베크만 쿨터 다이애그노스틱스가 Access MeMed BV 분석에 대해 CE 마크 승인을 획득함. 유럽 내 제품 포트폴리오 확대로 긍정적인 영향이 예상됨.

Related Recent Events

View Full Timeline